微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Fulcrum Therapeutics (NASDAQ:FULC) +125%
Exagen (NASDAQ:XGN) +24%
Myomo (NYSE:MYO) +16%
IMV (NASDAQ:IMV) +8%
Allied Healthcare Products (NASDAQ:AHPI) +6%
Losers:...查看全文
$Exagen(XGN)$ ARS Annual Report to Security Holders Accession Number: 0001274737-23-000036 Act: 34 Size: 3 MB 网页链接
$Exagen(XGN)$ DEF 14A Other definitive proxy statements Accession Number: 0001274737-23-000034 Act: 34 Size: 1 MB 网页链接
$Exagen(XGN)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001274737-23-000035 Act: 34 Size: 444 KB 网页链接
$Exagen(XGN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001274737-23-000019 Act: 34 Size: 9 MB 网页链接
$Exagen(XGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001274737-23-000017 Act: 34 Size: 292 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-23-000014 Size: 4 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-23-000013 Size: 4 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-23-000011 Size: 5 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-23-000012 Size: 5 KB 网页链接
$Exagen(XGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-23-001705 Act: 34 Size: 61 KB 网页链接